Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FROSTY: Laninamivir Octanoate in Pediatric Influenza
NCT02014649Phase 2Terminated
- Sponsor
- Biota Holdings Limited
- Start
- Nov 2013
- Primary completion
- Apr 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of laninamivir octanoate in influenza, sponsored by Biota Holdings Limited. Started Nov 2013; status: terminated.
02
Drugs
laninamivir octanoate
03
Conditions
influenza
Beyond the preview
Go deeper on NCT02014649.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02014649.